Abstract
Cholestatic jaundice in infancy occurs in ∼1 in 2,500 term infants and 25% of cases are genetically determined [ 1]. An accurate diagnosis is crucial for clinicians to provide timely and personalized management. Despite the increasing application of whole-exome sequencing (WES), the genetic diagnosis of some patients remains unclear.
Keywords
Funding Information
  • National key research and development program
  • Ministry of Science and Technology
  • People’s Republic of China (2021YFC2700800)
  • Shanghai Municipal Commission of Science and Technology Research Project (19JC1411002)

This publication has 7 references indexed in Scilit: